公开(公告)号：US20090203911A1

公开(公告)日：2009-08-13

申请号：US12189590

申请日：2008-08-11

申请人： Shuhei MIYAZAWA ,  Masanobu Shinoda ,  Tetsuya Kawahara ,  Nobuhisa Watanabe ,  Hitoshi Harada ,  Daisuke Iida ,  Hiroki Terauchi ,  Junichi Nagakawa ,  Hideaki Fujisaki ,  Atsuhiko Kubota ,  Masato Ueda

发明人： Shuhei MIYAZAWA ,  Masanobu Shinoda ,  Tetsuya Kawahara ,  Nobuhisa Watanabe ,  Hitoshi Harada ,  Daisuke Iida ,  Hiroki Terauchi ,  Junichi Nagakawa ,  Hideaki Fujisaki ,  Atsuhiko Kubota ,  Masato Ueda

IPC分类号： C07D405/14 ,  C07D401/12

CPC分类号： C07D491/04 ,  C07D405/14 ,  C07D493/08 ,  C07D493/10

摘要： A novel chemical compound useful as a therapeutic or prophylactic agent for acid-related diseases is provided, which has an excellent inhibitory effect against gastric acid secretion, an excellent effect of maintaining the inhibitory effect against gastric acid secretion, thereby maintaining intragastric pH high for a long time, and having more safety and appropriate physicochemical stability. Provided is a compound represented by where R1 and R3 may be the same or different and each represent a hydrogen atom or a C1-C6 alkyl group; R2 represents (5,5-dimethyl-1,3-dioxan-2-yl)methoxy group, 5,7-dioxaspiro[2.5]oct-6-ylmethoxy group, 1,5,9-trioxaspiro[5.5]undec-3-ylmethoxy group, or (2,2-dimethyl-1,3-dioxan-5-yl)methoxy group; R4, R5, R6 and R7 represent a hydrogen atom, halogen atom, C1-C6 alkyl group, C1-C6 haloalkyl group, C1-C6 alkoxy group or C1-C6 haloalkoxy group; and W1 represents a single bond, methylene or ethylene group, a salt thereof or a solvate of these.

摘要翻译： 提供了可用作酸性相关疾病的治疗或预防剂的新型化合物，其对胃酸分泌具有优异的抑制作用，保持对胃酸分泌的抑制作用的优异效果，从而保持胃内pH高 长时间，具有更多的安全性和适当的物理化学稳定性。 提供一种化合物，其中R 1和R 3可以相同或不同，各自表示氢原子或C 1 -C 6烷基; R2代表（5,5-二甲基-1,3-二恶烷-2-基）甲氧基，5,7-二氧杂螺[2.5]辛-6-基甲氧基，1,5,9-三氧杂螺[5.5]十一烷-3 - 甲氧基或（2,2-二甲基-1,3-二恶烷-5-基）甲氧基; R4，R5，R6和R7表示氢原子，卤素原子，C1-C6烷基，C1-C6卤代烷基，C1-C6烷氧基或C1-C6卤代烷氧基; W1表示单键，亚甲基或亚乙基，它们的盐或它们的溶剂合物。

公开(公告)号：US08124780B2

公开(公告)日：2012-02-28

申请号：US12189590

申请日：2008-08-11

申请人： Shuhei Miyazawa ,  Masanobu Shinoda ,  Tetsuya Kawahara ,  Nobuhisa Watanabe ,  Hitoshi Harada ,  Daisuke Iida ,  Hiroki Terauchi ,  Junichi Nagakawa ,  Hideaki Fujisaki ,  Atsuhiko Kubota ,  Masato Ueda

发明人： Shuhei Miyazawa ,  Masanobu Shinoda ,  Tetsuya Kawahara ,  Nobuhisa Watanabe ,  Hitoshi Harada ,  Daisuke Iida ,  Hiroki Terauchi ,  Junichi Nagakawa ,  Hideaki Fujisaki ,  Atsuhiko Kubota ,  Masato Ueda

IPC分类号： C07D401/12

CPC分类号： C07D491/04 ,  C07D405/14 ,  C07D493/08 ,  C07D493/10

摘要： A novel chemical compound useful as a therapeutic or prophylactic agent for acid-related diseases is provided, which has an excellent inhibitory effect against gastric acid secretion, an excellent effect of maintaining the inhibitory effect against gastric acid secretion, thereby maintaining intragastric pH high for a long time, and having more safety and appropriate physicochemical stability. Provided is a compound represented by where R1 and R3 may be the same or different and each represent a hydrogen atom or a C1-C6 alkyl group; R2 represents (5,5-dimethyl-1,3-dioxan-2-yl)methoxy group, 5,7-dioxaspiro[2.5]oct-6-ylmethoxy group, 1,5,9-trioxaspiro[5.5]undec-3-ylmethoxy group, or (2,2-dimethyl-1,3-dioxan-5-yl)methoxy group; R4, R5, R6 and R7 represent a hydrogen atom, halogen atom, C1-C6 alkyl group, C1-C6 haloalkyl group, C1-C6 alkoxy group or C1-C6 haloalkoxy group; and W1 represents a single bond, methylene or ethylene group, a salt thereof or a solvate of these.

摘要翻译： 提供了可用作酸性相关疾病的治疗或预防剂的新型化合物，其对胃酸分泌具有优异的抑制作用，保持对胃酸分泌的抑制作用的优异效果，从而保持胃内pH高 长时间，具有更多的安全性和适当的物理化学稳定性。 提供一种化合物，其中R 1和R 3可以相同或不同，各自表示氢原子或C 1 -C 6烷基; R2代表（5,5-二甲基-1,3-二恶烷-2-基）甲氧基，5,7-二氧杂螺[2.5]辛-6-基甲氧基，1,5,9-三氧杂螺[5.5]十一烷-3 - 甲氧基或（2,2-二甲基-1,3-二恶烷-5-基）甲氧基; R4，R5，R6和R7表示氢原子，卤素原子，C1-C6烷基，C1-C6卤代烷基，C1-C6烷氧基或C1-C6卤代烷氧基; W1表示单键，亚甲基或亚乙基，它们的盐或它们的溶剂合物。

公开(公告)号：US07425634B2

公开(公告)日：2008-09-16

申请号：US11520838

申请日：2006-09-14

申请人： Shuhei Miyazawa ,  Masanobu Shinoda ,  Tetsuya Kawahara ,  Nobuhisa Watanabe ,  Hitoshi Harada ,  Daisuke Iida ,  Hiroki Terauchi ,  Junichi Nagakawa ,  Hideaki Fujisaki ,  Atsuhiko Kubota ,  Masato Ueda

发明人： Shuhei Miyazawa ,  Masanobu Shinoda ,  Tetsuya Kawahara ,  Nobuhisa Watanabe ,  Hitoshi Harada ,  Daisuke Iida ,  Hiroki Terauchi ,  Junichi Nagakawa ,  Hideaki Fujisaki ,  Atsuhiko Kubota ,  Masato Ueda

IPC分类号： C07D401/12

CPC分类号： C07D491/04 ,  C07D405/14 ,  C07D493/08 ,  C07D493/10

摘要： An object of the present invention is to provide a novel chemical compound useful as a therapeutic or prophylactic agent for acid-related diseases, having an excellent inhibitory effect against gastric acid secretion, an excellent effect of maintaining the inhibitory effect against gastric acid secretion, thereby maintaining intragastric pH high for a long time, and having more safety and appropriate physicochemical stability.Provided is a compound represented by where R1 and R3 may be the same or different and each represent a hydrogen atom or a C1-C6 alkyl group; R2 represents (5,5-dimethyl-1,3-dioxan-2-yl)methoxy group, 5,7-dioxaspiro[2.5]oct-6-ylmethoxy group, 1,5,9-trioxaspiro[5.5]undec-3-ylmethoxy group, or (2,2-dimethyl-1,3-dioxan-5-yl)methoxy group; R4, R5, R6 and R7 represent a hydrogen atom, halogen atom, C1-C6 alkyl group, C1-C6 haloalkyl group, C1-C6 alkoxy group or C1-C6 haloalkoxy group; and W1 represents a single bond, methylene or ethylene group, a salt thereof or a solvate of these.

摘要翻译： 本发明的目的是提供一种新颖的化合物，其可用作酸性相关疾病的治疗或预防剂，对胃酸分泌具有优异的抑制作用，具有保持对胃酸分泌的抑制作用的优异效果，从而 长时间保持胃内pH高，并具有更多的安全性和适当的物理化学稳定性。 其中R 1和R 3可以相同或不同，表示氢原子或C1-C6烷基; R 5表示（5,5-二甲基-1,3-二恶烷-2-基）甲氧基，5,7-二氧杂螺[2.5]辛-6-基甲氧基，1,5,9 - 三氧杂螺[5.5]十一烷-3-基甲氧基或（2,2-二甲基-1,3-二恶烷-5-基）甲氧基; R 4，R 5，R 6和R 7表示氢原子，卤素原子，C 1 -C 6 烷基，C1-C6卤代烷基，C1-C6烷氧基或C1-C6卤代烷氧基; 和W 1表示单键，亚甲基或亚乙基，其盐或它们的溶剂合物。

公开(公告)号：US20070015782A1

公开(公告)日：2007-01-18

申请号：US11403815

申请日：2006-04-14

申请人： Shuhei Miyazawa ,  Masanobu Shinoda ,  Tetsuya Kawahara ,  Nobuhisa Watanabe ,  Hitoshi Harada ,  Daisuke Iida ,  Hiroki Terauchi ,  Junichi Nagakawa ,  Hideaki Fujisaki ,  Atsuhiko Kubota ,  Masato Ueda

发明人： Shuhei Miyazawa ,  Masanobu Shinoda ,  Tetsuya Kawahara ,  Nobuhisa Watanabe ,  Hitoshi Harada ,  Daisuke Iida ,  Hiroki Terauchi ,  Junichi Nagakawa ,  Hideaki Fujisaki ,  Atsuhiko Kubota ,  Masato Ueda

IPC分类号： A61K31/4747 ,  A61K31/4439 ,  C07D491/14

CPC分类号： C07D491/04 ,  C07D405/14 ,  C07D493/08 ,  C07D493/10

摘要： An object of the present invention is to provide a novel chemical compound useful as a therapeutic or prophylactic agent for acid-related diseases, having an excellent inhibitory effect against gastric acid secretion, an excellent effect of maintaining the inhibitory effect against gastric acid secretion, thereby maintaining intragastric pH high for a long time, and having more safety and appropriate physicochemical stability. Provided is a compound represented by where R1 and R3 may be the same or different and each represent a hydrogen atom or a C1-C6 alkyl group; R2 represents (5,5-dimethyl-1,3-dioxan-2-yl)methoxy group, 5,7-dioxaspiro[2.5]oct-6-ylmethoxy group, 1,5,9-trioxaspiro[5.5]undec-3-ylmethoxy group, or (2,2-dimethyl-1,3-dioxan-5-yl)methoxy group; R4, R5, R6 and R7 represent a hydrogen atom, halogen atom, C1-C6 alkyl group, C1-C6 haloalkyl group, C1-C6 alkoxy group or C1-C6 haloalkoxy group; and W1 represents a single bond, methylene or ethylene group, a salt thereof or a solvate of these.

公开(公告)号：US20070010542A1

公开(公告)日：2007-01-11

申请号：US11520838

申请日：2006-09-14

申请人： Shuhei Miyazawa ,  Masanobu Shinoda ,  Tetsuya Kawahara ,  Nobuhisa Watanabe ,  Hitoshi Harada ,  Daisuke Iida ,  Hiroki Terauchi ,  Junichi Nagakawa ,  Hideaki Fujisaki ,  Atsuhiko Kubota ,  Masato Ueda

发明人： Shuhei Miyazawa ,  Masanobu Shinoda ,  Tetsuya Kawahara ,  Nobuhisa Watanabe ,  Hitoshi Harada ,  Daisuke Iida ,  Hiroki Terauchi ,  Junichi Nagakawa ,  Hideaki Fujisaki ,  Atsuhiko Kubota ,  Masato Ueda

IPC分类号： A61K31/4747 ,  A61K31/4439 ,  C07D405/14

CPC分类号： C07D491/04 ,  C07D405/14 ,  C07D493/08 ,  C07D493/10

摘要： An object of the present invention is to provide a novel chemical compound useful as a therapeutic or prophylactic agent for acid-related diseases, having an excellent inhibitory effect against gastric acid secretion, an excellent effect of maintaining the inhibitory effect against gastric acid secretion, thereby maintaining intragastric pH high for a long time, and having more safety and appropriate physicochemical stability. Provided is a compound represented by where R1 and R3 may be the same or different and each represent a hydrogen atom or a C1-C6 alkyl group; R2 represents (5,5-dimethyl-1,3-dioxan-2-yl)methoxy group, 5,7-dioxaspiro[2.5]oct-6-ylmethoxy group, 1,5,9-trioxaspiro[5.5]undec-3-ylmethoxy group, or (2,2-dimethyl-1,3-dioxan-5-yl)methoxy group; R4, R5, R6 and R7 represent a hydrogen atom, halogen atom, C1-C6 alkyl group, C1-C6 haloalkyl group, C1-C6 alkoxy group or C1-C6 haloalkoxy group; and W1 represents a single bond, methylene or ethylene group, a salt thereof or a solvate of these.

摘要翻译： 本发明的目的是提供一种新颖的化合物，其可用作酸性相关疾病的治疗或预防剂，对胃酸分泌具有优异的抑制作用，具有保持对胃酸分泌的抑制作用的优异效果，从而 长时间保持胃内pH高，并具有更多的安全性和适当的物理化学稳定性。 其中R 1和R 3可以相同或不同，表示氢原子或C1-C6烷基; R 5表示（5,5-二甲基-1,3-二恶烷-2-基）甲氧基，5,7-二氧杂螺[2.5]辛-6-基甲氧基，1,5,9 - 三氧杂螺[5.5]十一烷-3-基甲氧基或（2,2-二甲基-1,3-二恶烷-5-基）甲氧基; R 4，R 5，R 6和R 7表示氢原子，卤素原子，C 1 -C 6 烷基，C1-C6卤代烷基，C1-C6烷氧基或C1-C6卤代烷氧基; 和W 1表示单键，亚甲基或亚乙基，其盐或它们的溶剂合物。

公开(公告)号：US20090182149A1

公开(公告)日：2009-07-16

申请号：US12296902

申请日：2006-10-13

申请人： Tetsuya Kawahara ,  Hitoshi Harada ,  Hiroki Terauchi ,  Nobuhisa Watanabe ,  Masato Ueda ,  Atsushi Kamada ,  Sachiko Kikuchi ,  Hiroshi Ishihara ,  Koichi Koyama

发明人： Tetsuya Kawahara ,  Hitoshi Harada ,  Hiroki Terauchi ,  Nobuhisa Watanabe ,  Masato Ueda ,  Atsushi Kamada ,  Sachiko Kikuchi ,  Hiroshi Ishihara ,  Koichi Koyama

IPC分类号： C07D405/14

CPC分类号： C07D405/14

摘要： Salts of 2-[({4-[(2,2-dimethyl-1,3-dioxan-5-yl)methoxy]-3,5-dimethylpyridin-2-yl}methyl)sulfinyl]-1H-benzimidazole and their crystalline and amorphous forms.

摘要翻译： 2 - [（{4 - [（2,2-二甲基-1,3-二恶烷-5-基）甲氧基] -3,5-二甲基吡啶-2-基}甲基）亚磺酰基] -1H-苯并咪唑的盐及其 晶体和无定形形式。

公开(公告)号：US07244730B2

公开(公告)日：2007-07-17

申请号：US10475188

申请日：2002-04-19

申请人： Shuichi Suzuki ,  Makoto Kotake ,  Mitsuaki Miyamoto ,  Tetsuya Kawahara ,  Akiharu Kajiwara ,  Ieharu Hishinuma ,  Kazuo Okano ,  Syuhei Miyazawa ,  Richard Clark ,  Fumihiro Ozaki ,  Nobuaki Sato ,  Masanobu Shinoda ,  Atsushi Kamada ,  Itaru Tsukada ,  Fumiyoshi Matsuura ,  Yoshimitsu Naoe ,  Taro Terauchi ,  Yoshiaki Oohashi ,  Osamu Ito ,  Hiroshi Tanaka ,  Takashi Musya ,  Motoji Kogushi ,  Tsutomu Kawada ,  Toshiyuki Matsuoka ,  Hiroko Kobayashi ,  Ken-ichi Chiba ,  Akifumi Kimura ,  Naoto Ono

发明人： Shuichi Suzuki ,  Makoto Kotake ,  Mitsuaki Miyamoto ,  Tetsuya Kawahara ,  Akiharu Kajiwara ,  Ieharu Hishinuma ,  Kazuo Okano ,  Syuhei Miyazawa ,  Richard Clark ,  Fumihiro Ozaki ,  Nobuaki Sato ,  Masanobu Shinoda ,  Atsushi Kamada ,  Itaru Tsukada ,  Fumiyoshi Matsuura ,  Yoshimitsu Naoe ,  Taro Terauchi ,  Yoshiaki Oohashi ,  Osamu Ito ,  Hiroshi Tanaka ,  Takashi Musya ,  Motoji Kogushi ,  Tsutomu Kawada ,  Toshiyuki Matsuoka ,  Hiroko Kobayashi ,  Ken-ichi Chiba ,  Akifumi Kimura ,  Naoto Ono

IPC分类号： A61K31/535 ,  A61K31/40 ,  C07D265/30 ,  C07D241/04 ,  C07D209/44

CPC分类号： C07D209/44

摘要： A 2-iminopyrrolidine derivative represented by the formula: {wherein ring B represents a benzene ring, pyridine ring, etc.; R101–R103 represent hydrogen, halogen, C1-6 alkyl, etc.; R5 represents hydrogen, C1-6 alkyl, C1-6 alkoxy-C1-6 alkyl, etc.; R6 represents hydrogen, C1-6 alkyl, C1-6 alkyloxycarbonyl, etc.; Y1 represents a single bond, —CH2—, etc.; Y2 represents a single bond, —CO—, etc.; and Ar represents hydrogen, a group represented by the formula: [wherein R10—R14 represent hydrogen, C1-6 alkyl, hydroxyl, C1-6 alkoxy, etc.; and R11 and R12 or R12 and R13 may bond together to form a 5- to 8-membered heterocyclic ring], etc.}, or a salt thereof.

摘要翻译： 由下式表示的2-亚氨基吡咯烷衍生物：其中环B表示苯环，吡啶环等; R 101为-O-，卤素，C 1-6烷基等; R 5表示氢，C 1-6烷基，C 1-6烷氧基-C 1-6烷基 等等 R 6表示氢，C 1-6烷基，C 1-6烷氧基羰基等; Y 1表示单键，-CH 2 - 等; Y 2表示单键，-CO-等; 和Ar表示氢，由下式表示的基团：其中R 10 -R 14表示氢，C 1-6烷基，羟基 C 1-6烷氧基等; 并且R 11和R 12或R 12和R 13可以键合在一起形成5-8个 - 杂环]等，或其盐。

公开(公告)号：US5438045A

公开(公告)日：1995-08-01

申请号：US52721

申请日：1993-04-27

申请人： Kazuo Okano ,  Shuhei Miyazawa ,  Richard S. J. Clark ,  Shinya Abe ,  Tetsuya Kawahara ,  Naoyuki Shimomura ,  Osamu Asano ,  Hiroyuki Yoshimura ,  Mitsuaki Miyamoto ,  Yoshimori Sakuma ,  Kenzo Muramoto ,  Hiroshi Obaishi ,  Koukichi Harada ,  Hajime Tsunoda ,  Satoshi Katayama ,  Kouji Yamada ,  Shigeru Souda ,  Yoshimasa Machida ,  Kouichi Katayama ,  Isao Yamatsu

发明人： Kazuo Okano ,  Shuhei Miyazawa ,  Richard S. J. Clark ,  Shinya Abe ,  Tetsuya Kawahara ,  Naoyuki Shimomura ,  Osamu Asano ,  Hiroyuki Yoshimura ,  Mitsuaki Miyamoto ,  Yoshimori Sakuma ,  Kenzo Muramoto ,  Hiroshi Obaishi ,  Koukichi Harada ,  Hajime Tsunoda ,  Satoshi Katayama ,  Kouji Yamada ,  Shigeru Souda ,  Yoshimasa Machida ,  Kouichi Katayama ,  Isao Yamatsu

IPC分类号： C07D495/14 ,  C07D495/22 ,  A61K31/55

CPC分类号： C07D495/14

摘要： A triazolo-1,4-di-azepine compound of the below given formula and a pharmacologically acceptable salt thereof are disclosed and useful in the pharmaceutical field, especially to allergic diseases. ##STR1## in which R1 and R2 are hydrogen or an alkyl, R3 is hydrogen or a halogen, R4 is hydrogen or an alkyl, X is --OOO--, --NHCO--, --CO-- or others and Y is a cycloalkyl, a cycloalkylalkyl, an alkynyl or others.

摘要翻译： 公开了以下给定式的三唑并-1,4-二氮杂化合物及其药理学上可接受的盐，尤其适用于过敏性疾病。 其中R 1和R 2是氢或烷基，R 3是氢或卤素，R 4是氢或烷基，X是-O-，-NHCO-，-CO-或其它，Y是环烷基， 环烷基烷基，炔基等。

公开(公告)号：US5262565A

公开(公告)日：1993-11-16

申请号：US790541

申请日：1991-11-12

申请人： Hiroyuki Yoshimura ,  Shinya Abe ,  Tetsuya Kawahara ,  Takashi Inoue ,  Hiroshi Shirota ,  Kenichi Chiba ,  Kenichi Kusube ,  Toru Horie ,  Takeshi Suzuki ,  Isao Yamatsu ,  Naoyuki Shimomura ,  Kazuo Okano ,  Richard S. J. Clark ,  Takashi Mori ,  Shuhei Miyazawa ,  Ryoichi Hashida ,  Kenzo Muramoto ,  Koukichi Harada

发明人： Hiroyuki Yoshimura ,  Shinya Abe ,  Tetsuya Kawahara ,  Takashi Inoue ,  Hiroshi Shirota ,  Kenichi Chiba ,  Kenichi Kusube ,  Toru Horie ,  Takeshi Suzuki ,  Isao Yamatsu ,  Naoyuki Shimomura ,  Kazuo Okano ,  Richard S. J. Clark ,  Takashi Mori ,  Shuhei Miyazawa ,  Ryoichi Hashida ,  Kenzo Muramoto ,  Koukichi Harada

IPC分类号： A61K31/165 ,  A61K31/19 ,  A61K31/192 ,  A61K31/197 ,  A61K31/215 ,  A61K31/22 ,  A61K31/222 ,  A61K31/275 ,  A61P19/02 ,  A61P25/04 ,  A61P29/00 ,  A61P43/00 ,  C07C39/40 ,  C07C43/20 ,  C07C43/23 ,  C07C43/253 ,  C07C45/00 ,  C07C47/575 ,  C07C59/52 ,  C07C59/64 ,  C07C59/72 ,  C07C59/84 ,  C07C59/90 ,  C07C69/157 ,  C07C69/734 ,  C07C69/738 ,  C07C235/34 ,  C07C251/48 ,  C07C255/41 ,  C07C62/06 ,  C07C69/76

CPC分类号： C07C255/41 ,  C07C251/48 ,  C07C39/40 ,  C07C43/202 ,  C07C43/23 ,  C07C43/253 ,  C07C45/00 ,  C07C47/575 ,  C07C59/52 ,  C07C59/64 ,  C07C59/72 ,  C07C59/90 ,  C07C69/734 ,  C07C69/738 ,  C07C2101/08

摘要： Compounds of the formula: ##STR1## where R.sup.1 is a hydrogen atom or a lower alkyl group;R.sub.2 is a lower alkoxy group;R.sub.3 is a hydroxyl or lower alkoxy group;Z is represented by the formula: ##STR2## where R.sub.2 and R.sub.3 may be the same or different from each other and each stands for a hydrogen atom or a lower alkyl;Y is represented by the formula: --(CH.sub.2).sub.n -- where n is 0 or an integer of 1 to 2 or a group represented by the formula: ##STR3## where R.sup.2 and R.sup.3 may be the same or different from each other and each stands for a lower alkyl group; andR.sup.4 represents a group of the formula: ##STR4## where p is 0 or an integer of 1 to 3 and R.sup.12 is hydrogen, a halogen atom, a lower alkyl or a lower alkoxy group a hydrogen atom, R.sup.2 is a methoxy group, R.sup.3 is a hydroxy group and R.sup.4 is a benzyl group having anti-inflammatory activity.

公开(公告)号：US20050004197A1

公开(公告)日：2005-01-06

申请号：US10475118

申请日：2002-04-19

申请人： Shichi Suzuki ,  Makoto Kotake ,  Mitsuaki Miyamoto ,  Tetsuya Kawahara ,  Akiharu Kajiwara ,  Ieharu Hishinuma ,  Kazuo Okano ,  Syuhei Miyazawa ,  Richard Clark ,  Fumuhiro Ozaki ,  Nobuaki Sato ,  Masanobu Shinoda ,  Atsushi Kamada ,  Itaru Tsukuda ,  Fumiyoshi Maatsuura ,  Yoshimitsu Naoe ,  Taro Terauchi ,  Yoshiaki Oohashi ,  Osamu Ito ,  Hiroshi Tanaka ,  Takashi Musha ,  Motoji Kogushi ,  Tsutomu Kawata ,  Toshiyuki Matsuoka ,  Hiroko Kobayashi ,  Ken-Ichi Chiba ,  Akifumi Kimura ,  Naoto Ono

发明人： Shichi Suzuki ,  Makoto Kotake ,  Mitsuaki Miyamoto ,  Tetsuya Kawahara ,  Akiharu Kajiwara ,  Ieharu Hishinuma ,  Kazuo Okano ,  Syuhei Miyazawa ,  Richard Clark ,  Fumuhiro Ozaki ,  Nobuaki Sato ,  Masanobu Shinoda ,  Atsushi Kamada ,  Itaru Tsukuda ,  Fumiyoshi Maatsuura ,  Yoshimitsu Naoe ,  Taro Terauchi ,  Yoshiaki Oohashi ,  Osamu Ito ,  Hiroshi Tanaka ,  Takashi Musha ,  Motoji Kogushi ,  Tsutomu Kawata ,  Toshiyuki Matsuoka ,  Hiroko Kobayashi ,  Ken-Ichi Chiba ,  Akifumi Kimura ,  Naoto Ono

IPC分类号： A61K20060101 ,  A61K31/403 ,  A61K31/4035 ,  A61K31/4178 ,  A61K31/4184 ,  A61K31/422 ,  A61K31/437 ,  A61K31/454 ,  A61K31/496 ,  A61K31/5377 ,  A61K31/538 ,  A61P20060101 ,  A61P7/02 ,  A61P9/00 ,  A61P9/10 ,  A61P9/12 ,  A61P11/00 ,  A61P11/06 ,  A61P13/12 ,  A61P19/10 ,  A61P25/00 ,  A61P29/00 ,  A61P35/00 ,  A61P43/00 ,  C07D20060101 ,  C07D207/22 ,  C07D207/24 ,  C07D207/26 ,  C07D207/263 ,  C07D207/267 ,  C07D207/34 ,  C07D209/44 ,  C07D209/52 ,  C07D209/54 ,  C07D209/62 ,  C07D209/96 ,  C07D213/73 ,  C07D213/74 ,  C07D233/46 ,  C07D233/66 ,  C07D233/88 ,  C07D233/90 ,  C07D235/30 ,  C07D249/14 ,  C07D261/14 ,  C07D401/04 ,  C07D401/06 ,  C07D401/10 ,  C07D401/12 ,  C07D403/04 ,  C07D403/06 ,  C07D403/10 ,  C07D403/12 ,  C07D405/06 ,  C07D409/04 ,  C07D409/06 ,  C07D409/10 ,  C07D413/06 ,  C07D413/10 ,  C07D413/12 ,  C07D413/14 ,  C07D417/06 ,  C07D417/10 ,  C07D471/04 ,  C07D487/04 ,  C07D491/10 ,  C07D498/04 ,  C07D521/00 ,  A61K31/4172

CPC分类号： C07D209/44

摘要： A 2-iminoimidazole derivative represented by the formula: {wherein R1, R2 and R3 represent hydrogen, optionally substituted C1-6 alkyl, etc.; R6 represents hydrogen, C1-6 alkyl, C1-6 alkyloxycarbonyl, etc.; Y1 represents a single bond, —CH2—, etc.; Y2 represents a single bond, —CO—, etc.; and Ar represents hydrogen, a group represented by the formula: [wherein R10-R14 represent hydrogen, C1-6 alkyl, hydroxyl, C1-6 alkoxy, etc., and R11 and R12 or R12 and R13 may bond together to form a 5- to 8-membered heterocycle], etc.}or salt thereof.

摘要翻译： 由下式表示的2-亚氨基咪唑衍生物：其中R 1，R 2和R 3表示氢，任选取代的C 1-6烷基等; R 6表示氢，C 1-6烷基，C 1-6烷氧羰基等; Y 1表示单键，-CH 2 - 等; Y 2表示单键，-CO-等; 并且Ar表示氢，由下式表示的基团：其中R 10 -R 14表示氢，C 1-6烷基，羟基，C 1-6烷氧基等，R 11和R 12 >或R 12和R 13可以键合在一起形成5-至8-元杂环等}或其盐。